EDGAR Filing Documents for 0001193125-04-022813

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-04-022813

Filing Date

2004-02-13

Accepted

2004-02-13 14:08:57

Documents

Effectiveness Date

2004-02-13

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-8	ds8.htm	S-8	57750
3	AMENDED & RESTATED GENESOFT PHARMACEUTICALS 1998 STOCK OPTION ISSUANCE PLAN	dex41.htm	EX-4.1	81755
4	FORM OF STOCK OPTION AGREEMENT	dex42.htm	EX-4.2	43811
5	FORM OF STOCK OPTION ASSUMPTION AGREEMENT	dex43.htm	EX-4.3	15996
6	OPINION OF ROPES & GRAY LLP	dex51.htm	EX-5.1	6045
7	CONSENT OF INDEPENDENT AUDITORS	dex232.htm	EX-23.2	1694
8	CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS	dex233.htm	EX-23.3	1619
	Complete submission text file	0001193125-04-022813.txt		211062

Mailing Address 100 BEAVER STREET WALTHAM MA 02453

Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300

GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)